CD37 and diffuse large B-cell lymphoma: It is worth mentioning that CD37 has also been presented as a tumor suppressor gene, possibly down-regulated in some DLBCL patients [163, 164] and loss of CD37 expression due to its gene homozygous loss has been reported in a DLBCL cell line with acquired resistance to naratuximab emtansine [165].